On November 15-19, the annual Human Proteome Organization (HUPO) congress took place. This event has the goal to showcase, promote and foster the development of new technologies in the field of proteomics. Proteomics is the study of all proteins in an organism or cell. Proteomics typically uses mass spectrometry to [...]
Op donderdag 9 december was SYMPHONY uitgenodigd om samen met de NVHP een webinar te organiseren voor de leden van de NVHP en overige belangstellende. Tijdens deze webinar hebben de aanwezige kennis kunnen maken met het nieuwe 2-jarige project genaamd Partitura. Partitura is ontstaan uit een samenwerking tussen verschillende werkpakketten [...]
Wat ga je onderzoeken? Binnen de Apotheek Amsterdam-UMC locatie AMC wordt onder leiding van prof. Ron Mathôt onderzoek gedaan naar de populatie farmacokinetiek (PK) en farmacodynamiek (PD) van geneesmiddelen. Dit onderzoek heeft tot doel de werkzaamheid van de geneesmiddelen te optimaliseren. Bij dit onderzoek wordt o.a. gebruik gemaakt van [...]
The aim of the project “SYMPHONY: Orchestrating personalized treatment for patients with bleeding disorders” is to establish best treatment choice for each individual with a bleeding disorder based on bleeding tendency. This will be achieved by improving current diagnostic tests to measure hemostatic potential and by performing fundamental research [...]
Thromb Haemost 2021;121:1409–1416
Res Pract Thromb Haemost. 2021;5:e12621
Interview Shannon van Hoorn Born: in Utrecht, The Netherlands Lives in Rotterdam Studied: BSc Health Sciences, MSc Health Sciences and MSc Business Administration at the University of Twente First job: Project employee at the Antoni van Leeuwenhoek hospital in Amsterdam Sports: I do fitness myself, but [...]
Lancet Haematol 2021; 8: e492–502
Haemophilia. 2021;27:974–983
On 17 – 21 July the annual International Society on Thrombosis and Haemostasis (ISTH) congress took place. The ISTH is an international congress were all new insights on both clinical and fundamental thrombosis and hemostasis research are presented. Some examples of the topics that were discussed are the use of the new von Willebrand Disease guidelines, treatment with new factor VIII replacement therapies, treatment based [...]
